What is Novavax's total equity?

Novavax (NVAX) reported total equity of -$144.76M in Q1 2026.

How has Novavax's total equity changed year-over-year?

Novavax's total equity decreased by 91.4% year-over-year, from -$75.64M to -$144.76M.

What is the long-term trend for Novavax's total equity?

Over 5 years (2020 to 2025), Novavax's total equity has grown at a -27.3% compound annual growth rate (CAGR), from $627.21M to -$127.75M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Novavax NVAX Total Equity

Total Equity at other companies

ModernaMRNA

$7.41B-26.4%

Roivant SciencesROIV

$4.53B-3.4%

Merck & Co.MRK

$45.88B-5.1%

Vaxcyte, Inc.PCVX

$3B-6.4%

Viridian Therapeutics, Inc.VRDN

$636.01M+5.2%

ALN

Alnylam PharmaceuticalsALNY

$1.08B+152%

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+28.6%

Enterprise value$1.53B+68.6%

P/S2.5×+1.5×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's total equity?: Novavax (NVAX) reported total equity of -$144.76M in Q1 2026.
How has Novavax's total equity changed year-over-year?: Novavax's total equity decreased by 91.4% year-over-year, from -$75.64M to -$144.76M.
What is the long-term trend for Novavax's total equity?: Over 5 years (2020 to 2025), Novavax's total equity has grown at a -27.3% compound annual growth rate (CAGR), from $627.21M to -$127.75M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.